Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
哺乳动物细胞中多顺反子 MicroRNA 的转录后调控
基本信息
- 批准号:8120353
- 负责人:
- 金额:$ 24.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-12 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAnimalsAwardBiochemicalBiochemistryBiogenesisBioinformaticsBiologyCD8B1 geneCell DeathCellsComprehensionCore FacilityDataDevelopmentEctopic ExpressionEducational process of instructingExposure toFellowshipGene ExpressionGene Expression RegulationGenesGeneticGenomicsHeadImmunologistImmunologyIn VitroIndividualInstitutionKineticsKnowledgeLaboratoriesLarge Intestine CarcinomaLymphomaLymphomagenesisMYC geneMalignant NeoplasmsMammalian CellMentorsMessenger RNAMicroRNAsModelingMusMutant Strains MiceNCI Center for Cancer ResearchOncogenicPathway interactionsPhasePhysiologicalPlayPost-Transcriptional RegulationProcessProteinsRNARNA InterferenceRegulationRelative (related person)ResearchResourcesRoleSpecificityStagingT-LymphocyteThymocyte DevelopmentThymus GlandTimeTrainingTranscriptTumor BiologyTumor Cell LineTumor Suppressor GenesWorkc-myc Genescell typemembermouse modelprogramsresearch studyskillstherapeutic genethymocytetumor
项目摘要
DESCRIPTION (provided by applicant): Dr. Neilson is a trained developmental immunologist/mouse geneticist who has used the first portion of his postdoctoral fellowship in Phillip A. Sharp's lab at the the MIT Center for Cancer Research to gain a deeper understanding of short RNA biology, as well as to become facile with in vitro experimental approaches. Dr. Neilson's objective is to head an academic laboratory at a top research institution.
During the mentored phase of the award period, Dr. Neilson aims to strengthen his exposure to the fields of biochemistry and bioinformatics. Training in the latter field in particular is increasingly important. During the mentored phase of the proposal, Dr. Neilson will generate mice with conditional alleles of the miR-92-1 locus. He will also initiate a biochemical characterization of the oncogenic miR-17-92 cluster as outlined in the proposal. Dr. Sharp's ability to mentor this mode of experimentation is unparalleled. Simultaneously, Dr. Neilson will take academic and non-academic courses to become fluent in programming and bioinformatic approaches, and teach an advanced undergraduate course in short RNAs and immunology. MIT and the Center for Cancer research have outstanding core facilities and academic resources relevant to these purposes.
Once the mentored phase has been completed, Dr. Neilson and his trainees will continue the characterization of the mouse mutants proposed herein. Dr. Neilson's newly acquired biochemical and bioinformatic skill sets will be used in parallel with his existing knowledge of mammalian development and immunology to characterize the consequences of miR-92-1 disruption at the phenotypic, biochemical, and genomic levels. The consequences of miR-92-1 disruption in the context of the biochemical experiments performed during the mentored phase will be examined.
The discovery of gene regulation by a new class of genes termed miRNAs has fundamentally changed the scientific view of how cells control gene expression. Several of these genes have been implicated in cancer. A detailed understanding how miRNAs work and how they themselves are controlled will allow a fuller comprehension of mammalian biology, at the same time enabling more effective exploitation of the pathway giving rise to these genes for therapeutic purposes (RNAi).
描述(由申请人提供):Dr. Neilson是一名训练有素的发育免疫学家/小鼠遗传学家,他在菲利普A.夏普的实验室在麻省理工学院癌症研究中心,以获得更深入的了解短RNA生物学,以及成为在体外实验方法的简易。尼尔森博士的目标是在一家顶级研究机构领导一个学术实验室。
在获奖期间的指导阶段,尼尔森博士的目标是加强他对生物化学和生物信息学领域的接触。后一领域的培训尤其日益重要。在建议的指导阶段,Neilson博士将产生具有miR-92-1基因座的条件等位基因的小鼠。他还将启动致癌miR-17-92簇的生物化学表征,如提案中所述。夏普博士指导这种实验模式的能力是无与伦比的。同时,Neilson博士将参加学术和非学术课程,以精通编程和生物信息学方法,并教授短RNA和免疫学的高级本科课程。麻省理工学院和癌症研究中心拥有与这些目的相关的杰出核心设施和学术资源。
一旦指导阶段完成,Neilson博士和他的学员将继续对本文提出的小鼠突变体进行表征。Neilson博士新获得的生物化学和生物信息学技能将与他现有的哺乳动物发育和免疫学知识并行使用,以表征miR-92-1在表型,生物化学和基因组水平上破坏的后果。将检查在指导阶段期间进行的生化实验背景下miR-92-1破坏的后果。
通过一类称为miRNAs的新基因进行基因调控的发现从根本上改变了细胞如何控制基因表达的科学观点。这些基因中有几个与癌症有关。详细了解miRNAs如何工作以及它们本身是如何被控制的,将有助于更全面地理解哺乳动物生物学,同时能够更有效地利用产生这些基因用于治疗目的(RNAi)的途径。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA cloning from cells of the immune system.
从免疫系统细胞克隆 MicroRNA。
- DOI:10.1007/978-1-60761-811-9_5
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Wu,Haoquan;Neilson,Joel;Manjunath,N
- 通讯作者:Manjunath,N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel R Neilson其他文献
Joel R Neilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel R Neilson', 18)}}的其他基金
Translational control of EMT by the CELF1 RNA Binding Protein
CELF1 RNA 结合蛋白对 EMT 的翻译控制
- 批准号:
10395222 - 财政年份:2021
- 资助金额:
$ 24.15万 - 项目类别:
Prospective Identification of Translational Regulators in EMT
EMT 中翻译调节因子的前瞻性鉴定
- 批准号:
8956695 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Translational control of EMT by the CELF1 RNA Binding Protein
CELF1 RNA 结合蛋白对 EMT 的翻译控制
- 批准号:
9766194 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Translational control of EMT by the CELF1 RNA Binding Protein
CELF1 RNA 结合蛋白对 EMT 的翻译控制
- 批准号:
9319243 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Prospective Identification of Translational Regulators in EMT
EMT 中翻译调节因子的前瞻性鉴定
- 批准号:
9068884 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
哺乳动物细胞中多顺反子 MicroRNA 的转录后调控
- 批准号:
7928216 - 财政年份:2008
- 资助金额:
$ 24.15万 - 项目类别:
Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
哺乳动物细胞中多顺反子 MicroRNA 的转录后调控
- 批准号:
7568843 - 财政年份:2008
- 资助金额:
$ 24.15万 - 项目类别:
Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
哺乳动物细胞中多顺反子 MicroRNA 的转录后调控
- 批准号:
7362080 - 财政年份:2008
- 资助金额:
$ 24.15万 - 项目类别:
Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
哺乳动物细胞中多顺反子 MicroRNA 的转录后调控
- 批准号:
7917095 - 财政年份:2008
- 资助金额:
$ 24.15万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 24.15万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 24.15万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 24.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 24.15万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 24.15万 - 项目类别: